This bill directs the National Institutes of Health to expand research efforts on triple-negative breast cancer, an aggressive form of breast cancer that disproportionately affects African-American and Hispanic women and accounts for 10–20 percent of all breast cancer cases. The legislation also requires the Centers for Disease Control and Prevention to develop and distribute public education materials about the disease, including information on its prevalence among minority women and available treatment options, while directing the Health Resources and Services Administration to provide similar information to healthcare providers to improve awareness and early detection. The bill authorizes unspecified funding for these research and education initiatives through fiscal year 2031, recognizing that African-American women are three times more likely than white women to develop triple-negative breast cancer and that early detection is critical since this type of cancer does not respond to hormone-based treatments. The legislation reflects Congress's concern that current data inadequately document the prevalence, costs, and prevention methods for triple-negative breast cancer, particularly among minority populations.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.